A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | X | Z

Articles are indexed by drug names, trade names and disease terms. Bold entries refer to major references.

Key Word / Drug Name
Issue #: Page #

A

abametapir 2:10
ABSSSI 3:10
acne 2:9; 4:9; 5:12
actinic keratosis 1:12; 2:9,12
adalimumab 2:10,11; 6:6,8
AGLE-102 1:12
alpha-adrenergic agonist 4:3-4
Amgevita® 2:10-11
anakinra 2:9,12
ANCA-associated vasculitis 6:12
androgen receptor inhibitor 2:9
anifrolumab 5:12
anti-neutrophil cytoplasmic
autoantibody-associated vasculitis 6:12
anti-TNF 2:1-5,10,11; 6:7-8
anti-acne 2:9
antibacterial 5:12
antibiotic 3:10; 4:3-4
anti-cancer 2:9
antifungal 1:5-10
antineoplastic 2:9; 5:12
antiparasitic 4:3-4
antiviral 4:14
apremilast 6:7
Arazlo™ 5:12
atezolizumab 2:9
atopic dermatitis 1:1-4; 2:9; 4:9-13,14 ; 6:12
avacopan 6:12
Avsola™ 2:11
axatilimab 3:10
azelaic acid 4:3-6

B

baby products 5:4
basal cell carcinoma 2:9,12
benzoyl peroxide 5:12
berotralstat 1:12; 2:10
betamethasone 2:11
bimekizumab 3:1-4
binimetinib 3:10
biologics 2:1-5,9-10; 6:4-10
biosimilar 2:10; 6:6,8
BRAF kinase inhibitor 2:9; 3:10
Braftovi® 3:10
brincidofovir 4:14
brodalumab 6:6,8
Bryhali™ 4:14
bullous pemphigoid 4:14
butorphanol 3:7
Bylvay™ 5:12

C

C1 esterase inhibitor 2:10
C5 complement inhibitor 4:14; 6:12
calcipotriene 2:11
cannabinoids 3:7-8
cellulite 2:9
cemiplimab 2:12
ceramide 4:10-13
certolizumab pegol 2:1-5; 6:6,8
Cervarix® 2:6-8
chemical depilatories 5:7-11
chlormethine hydrochloride 5:12
cidofovir 4:14
Cimzia® 2:1-5; 6:6,8
clascoterone 2:9
cleansers 4:9-13
cobimetinib 2:9
collagenase clostridium histolyticum 2:9
condyloma acuminata 2:6-8
contact dermatitis 4:9-13,14
coronavirus disease 2019 4:9
cortexolone 17α-propionate 2:9
corticosteroid 1:1-4; 2:11; 4:14; 6:1-3
Cosentyx® 4:14; 6:7-8
cosmetics 5:1-6
Cotellic® 2:9
COVID-19 4:9-13
crisaborole 1:1-4; 2:9
cutaneous T-cell lymphoma (CTCL) 5:12
cutaneous warts 2:6-8

D

decision-making 6:4-10
depilation 5:7-11
dermal fillers 2:10; 5:12
dermatomyositis 5:12
dermatophyte 1:5-10
dicarboxylic acid 4:3,7
difelikefalin 6:12
Duobrii™ 2:11; 6:1-3
dupilumab 2:9; 3:7
Dupixent® 2:9; 3:7
dystrophic epidermolysis bullosa 1:12

E

eczema 1:1-4; 2:9; 4:9-13,14; 6:12
education 6:4-10
efinaconazole 1:5-10
eflornithine hydrochloride 5:7,8,10,11
electrolysis 5:7-11; 6:10
Enbrel® 6:6,8
encapsulated cell therapy 3:10
encorafenib 3:10
epidermodysplasia verruciformis 2:6-8
epilation 5:7-11
epitheloid sarcoma 2:9
erratum 6:10
erythema 4:1-6
etanercept 6:6,8
Eucrisa® 1:1-4; 2:9

F

Fabry disease 3:10
fixed combination therapy 6:1-3
fragrance-free 5:1-6

G

Gardasil® 2:6-8
gene therapy 1:12
genital warts 2:6-8
golimumab 2:11
graft versus host disease (GVHD) 3:10; 6:12
granulomatosis with polyangiitis 6:12
guselkumab 2:11; 6:7-8

H

Haegarda® 2:10
hair dyes 5:5
hair removal 5:7-11; 6:10
halobetasol propionate 2:11; 4:14; 6:1-3
hand eczema 4:9-13
hedgehog pathway inhibitor 2:9
hereditary angioedema 2:10
hidradenitis suppurativa 2:10,11
HPV immunization 2:6-8
Hulio® 2:10,11
human papillomavirus (HPV) 2:6-8
Humira® 6:7-8
hyaluronic acid (HA) filler 2:10,12; 5:12
hypoallergenic 5:1-6
hypoplasminogenemia 4:14
Hyrimoz® 2:10,11

I

Idacio® 2:10,11
IL-12 2:11; 6:7-8
IL-17 3:1-4; 4:14; 6:6-8
IL-23 2:11; 6:7-8
immune globulin intravenous (IVIg) 5:12
infliximab 2:11; 6:6,8
ingenol mebutate 1:12
insect repellent 5:5
intense pulsed light (IPL) 5:8-10; 6:10
interleukin (IL)-1 2:9,12
irritant contact dermatitis 4:9-13,14
ivermectin 1:12; 4:3-4
ixekizumab 6:7-8

J

Jakafi® 6:12
Janus kinase (JAK) inhibitor 6:12
Jublia® 1:5-10
Juvéderm® Voluma™ XC 2:10

K

Kaposi sarcoma 2:9
keratinocyte carcinomas 2:6-8
Keytruda® 2:9; 5:12
Kimyrsa™ 3:10
Kineret® 2:9,12
Klisyri® 2:9,12
Korsuva™ 6:12
Koselugo® 2:10
KPL-716 1:12

L

labeling laws 5:1-6
laser therapy 4:4; 5:7-11; 6:10
Ledaga™ 5:12
Libtayo® 2:11
lice 1:12; 2:10
Livmarli™ 6:12

M

maralixibat 6:12
MEK inhibitor 2:9,10; 6:12
Mektovi® 3:10
melanoma 2:9,12; 3:10
microscopic polyangiitis 6:12
microtubule inhibitor 2:9,12
minocycline 2:11
moisturizers 4:9-13
monoclonal antibody 1:12; 2:1012; 3:1-4,5-8,10
mycosis fungoides 5:12

N

nail disorder 1:5-10
nalbuphine 3:7
naloxone 3:7
naltrexone 3:7
nemolizumab 3:5-8
neurofibromatosis 2:10; 6:12
NFX-179 6:12
nomacopan 4:14

O

obstetrics 2:1-5
Octagam® 5:12
odevixibat 5:12
Odomzo® 2:9
onychomycosis 1:5-10
opioid receptor modulation 3:7
Opzelura™ 6:12
oritavancin 3:10
Orladeyo™ 1:12
Otezla® 6:7

P

patient education 6:4-10
PD-L1 antibody 2:9,12
PDE4 inhibitor 1:1-4; 2:9; 6:7
pembrolizumab 2:9; 5:12
personal care products 5:1-6
personal protective equipment (PPE) 4:9
phenotype approach (rosacea) 4:1-6
phosphodiesterase-4 inhibitor 1:1-4; 2:9; 6:7
photodynamic therapy 5:7-11
phyma 4:1-6
Picato® 1:12
plasma kallikrein inhibitor 1:12
plasminogen 4:14
plucking 5:8-9
pomalidomide 2:9
Pomalyst® 2:9
pregnancy 2:1-5
programmed death receptor-1 (PD-1) 2:9,12; 5:12
pruritus 5:12; 6:12
psoriasis 2:1-5,10,11; 3:1-4; 4:14; 6:1-3,4-10
psoriatic arthritis 2:10,11; 4:14
prurigo nodularis 1:12; 3:5-8

R

Remicade® 6:6,8
Restylane® Contour™ 5:12
Restylane® Defyne™ 2:12
Restylane® Kysse™ 2:10
retinoid 4:1-4; 5:12; 6:1-3
risankizumab 6:7-8
rosacea 2:11; 4:1-6
ruxolitinib 6:12
Ryplazim® 4:14

S

Saphnelo™ 5:12
secukinumab 4:14; 6:7-8
selumetinib 2:10
sensitive skin 5:1-6
shared decision-making 6:4-10
Siliq® 6:6,8
Simponi® Aria™ 2:11
Sklice® 1:12
Skyrizi® 6:7-8
smallpox 4:14
sonidegib 2:9
squamous cell carcinoma 2:6-8,9; 5:12
Stelara® 2:11
sugaring 5:8-9
sunscreens 5:2-5
systemic lupus erythematosus 5:12

T

Taltz® 6:7-8
Tavneos™ 6:12
tazarotene 2:11; 5:12; 6:1-3
tazemetostat 2:9
Tecentriq® 2:9
telangiectasia 4:1-6
Tembexa® 4:14
threading 5:8-9
tirbanibulin 2:9,12
TNF-alpha 2:1-5,10,11; 6:6,8
topical treatment 1:1-4; 2:912
Tremfya® 2:11; 6:7-8
tretinoin 5:12
tumor necrosis factor-alpha 2:1-5,10,11; 6:6,8
Twyneo® 5:12

U

ustekinumab 2:11; 6:7-8

V

vaccines 2:6-8,12
Vaniqa® 5:7,8,10
vemurafenib 2:9
verruca vulgaris 2:6-8
vixarelimab 1:12

W

waxing 5:8-9
Winlevi® 2:9
Wynzora® 2:11

X

Xeglyze™ 2:10

Z

Zelboraf® 2:9
Zilxi™ 2:11

Purchase Article PDF for $1.99